';
ODP Announcement 21-031: UPDATE highlights that the American Rescue Plan Act of 2021 (ARPA) provides a temporary 10% increase to the federal medical assistance percentage (FMAP) for certain Medicaid expenditures for home and community-based services (HCBS). The funding is to be used to enhance, expand, or strengthen HCBS beyond what is available under the Medicaid program.
On June 3, CMS notified states that they have an additional year to use funding made available by ARPA, expanding eligible expenditures to March 31, 2025. To provide guidance about the process for providers to request one-time payments and address staff training, credentialing, and business associates programs for employment, the application deadline for this initiative has been extended to October 31, 2022.
Providers interested in applying will complete and submit the Staff Training, Credentialing, and Business Associates Programs for Employment Supplemental Payment Application and submit via email to Rick Smith. Applications will be accepted through October 31, 2022.
ODP Announcement 22-074 is in regards to the “Human Rights Webinars: Making A Determination” recordings and is an updated (renumbered) release from earlier this week. This announcement was released on June 27, 2022. This is the same announcement with a corrected announcement number dated June 29, 2022.
The Pennsylvania Senate today passed HB 1563 and HB 1561, sending the substance use disorder and mental health confidentiality-related bills to Gov. Wolf to sign into law. He is expected to sign both.
Both bills align Pennsylvania’s confidentiality laws with federal confidentiality laws, including 42 CFR and HIPAA. Barring a Gov. Wolf veto of HB 1563, Pennsylvania’s 4 Pa Code 255.5 will be eliminated.
Advocates of improved care coordination and integration have long pointed to 4 Pa Code 255.5 as a barrier, citing the limited amount of information allowed to be shared and the few entities with whom it could be shared, even with patient consent.
The Pennsylvania Department of Drug and Alcohol Programs (DDAP) today announced the availability of $3 million in funding for entities to provide pregnancy support services to address the needs of pregnant and postpartum women with substance use disorder (SUD).
Eligible applicants can find the project summary and budget on the Funding Opportunities page of the DDAP website. Approximately three to five grants, up to $600,000 each, will be awarded to help provide services, streamline care, and assure that this population is connected with the most appropriate resources to reach long-term recovery.
All applications must be submitted via email by 11:59 pm on Friday, July 29, 2022. Applications will be competitively reviewed and scored based upon the applicant’s adherence to the funding announcement guidelines and a timely submission to DDAP.
The grants are part of $59 million in federal funding awarded to Pennsylvania through the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Substance Abuse Prevention and Treatment Block Grant Program.
Questions regarding the grants and the application process can be emailed to DDAP.
ODP Announcement 22-076 serves to announce that the Consolidated, Community Living, and Person/Family Directed Support (P/FDS) Waiver renewals, collectively known as the Intellectual Disability/Autism (ID/A) waivers, will not be effective on July 1, 2022, as requested.
This extension does not apply to the Adult Autism Waiver (AAW). The currently-approved AAW was most recently amended on April 1, 2022.
Discussions between the Office of Developmental Programs (ODP) and the Centers for Medicare & Medicaid Services (CMS) have been occurring since the submission of the waiver renewals. During recent discussions, it has become clear that the process to renew the waivers will not be complete by July 1. ODP requested a 90-day extension of the currently-approved waivers on June 27, 2022, since the Consolidated and Person/Family Directed Support waivers expire on June 30, 2022. CMS granted the extension request on June 27, 2022.
Until CMS approves the ID/A waiver renewals, the waiver amendments approved with an effective date of June 1, 2022, remain in effect. They can be found on the Department of Human Services website at the following links:
The ID/A waiver renewals submitted to CMS on April 1, 2022, are also available.
Additional changes will be made to the waiver renewals as a result of ongoing discussions with CMS. ODP will inform all stakeholders when the waiver renewals have been approved. The final approved versions of the waivers will be made available online at that time.

Upcoming Meeting of the President’s Committee for People with Intellectual Disabilities
Thursday, July 28 | 12:00 pm – 4:00 pm ET
Register for the meeting.
About the President’s Committee for People with Intellectual Disabilities:
Initially established in 1966 by President Lyndon B. Johnson, the PCPID advises the President and the Secretary of Health and Human Services on a broad range of topics that impact people with intellectual disabilities, as well as the professional fields that support people with intellectual disabilities and their families. Its goal is to improve the quality of life experienced by people with intellectual disabilities by upholding their full citizenship rights, independence, self-determination, and lifelong participation in their communities.
The President’s Committee for People with Intellectual Disabilities (PCPID) will host a virtual meeting for its members to identify emerging topics to examine in the Committee’s Report to the President. All the PCPID meetings, in any format, are open to the public. This virtual meeting will be conducted in a presentation and discussion format. View more details published in the Federal Register notice.
Stakeholder input is very important to the PCPID. Comments and suggestions, especially from people with intellectual and developmental disabilities, are welcome at any time. If there are comments or feedback you would like to share with the PCPID as it begins to prioritize its work, please share them through this form. Comments received by June 30 will be shared with the PCPID at the July meeting. Comments received after June 30 will be compiled and shared with the PCPID quarterly.
FDA Safety Advisory (Issued June 28, 2022): Do not use neck floats with babies for water therapy interventions, especially with babies who have developmental delays or special health care needs.
See the full FDA Communication here.
If you have any questions, please contact RCPA Children’s Policy Director Jim Sharp. Please share with those in your networks. Thank you.